We have been active since 2012, focusing on developing 'BAK' company. The company was officially established in Istanbul, Turkey, in 2022.

Recognizing the importance of new technology, we aim to introduce our device, Mammowave, to enhance healthcare. Typically, government entities procure through tenders, but for Mammowave, our policy allows for direct purchase from our company. Our primary target is the governmental sector, followed by the private sector.

To establish trust as the foremost safe imaging system. To become the market leader within 3-5 years.

Most Mammo users are from government hospitals, accounting for about 70% of the market. Approximately 20% are from private hospitals, while less than 10% are imaging centers.